Results 1 to 10 of about 54,491 (199)
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association. [PDF]
Thromb JBackground Lupus anticoagulant (LA) is an in vitro phenomenon with prolongation of a phospholipid-dependent coagulation test which is not due to an inhibitor specific to a coagulation factor.
Li THS +4 more
europepmc +3 more sources
An investigation to find the correlation between lupus anticoagulant and coagulation abnormalities in COVID-19 patients; a narrative review [PDF]
Journal of Nephropathology, 2023 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19) which is associated with nonspecific respiratory syndromes, varying from mild symptoms of upper airway to required mechanical ventilation ...
Amir Aria +3 more
doaj +2 more sources
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays [PDF]
Scandinavian Journal of Clinical and Laboratory Investigation, 2018 Edoxaban is an oral direct factor Xa inhibitor for prophylaxis and treatment of thromboembolic disorders. The effects on common coagulation assays are clinically valuable information and in certain clinical situations a quick assessment of the ...
Andreas Hillarp +5 more
openalex +2 more sources
Journal of Medical Case Reports, 2022 Background Acquired hemophilia A is a disorder caused by autoantibodies against coagulation factor VIII that may present with severe bleeding. We report a rare case of acquired hemophilia A presenting with coexisting lupus anticoagulant.
Victor Chen +4 more
doaj +2 more sources
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. [PDF]
Journal of Clinical Investigation, 1980 Prolongation of all phospholipid-dependent coagulation tests was found in a patient with macroglobulinemia, despite absence of bleeding manifestations. The purified monoclonal IgM lambda protein and its Fabmu tryptic fragment induced similar changes in ...
Perumal Thiagarajan +2 more
openalex +2 more sources
TH Open, 2021 COVID-19 (coronavirus disease 2019) patients often show excessive activation of coagulation, associated with increased risk of thrombosis. However, the diagnostic value of coagulation at initial clinical evaluation is not clear.
Wolfgang Bauer +7 more
doaj +2 more sources
Acquired Hemophilia in a Patient With Rheumatoid Arthritis: Case Report and Literature Review [PDF]
Clinical Management Issues, 2018 Acquired hemophilia (AH) is a rare bleeding disorder caused by the spontaneous development of autoantibodies against coagulation factors, most commonly factor (F) VIII (acquired hemophilia A, AHA).
Masen Abdel Jaber +5 more
doaj +4 more sources
Blood, 2023 Rapid and reliable differentiation between bleeding and thrombotic tendency in cases with prolonged activated partial thromboplastin time (APTT) remains challenging in clinical practice, in particular, distinguishing cases positive for coagulation ...
Yushi Chikasawa +13 more
semanticscholar +1 more source
NOVA, 2023 Introduction. Thrombosis is associated with acquired risk factors or hypercoagulablestates. Antiphospholipid antibodies are found in infectious processes or associated with arterial or venous thrombosis.
Martha Castillo +5 more
semanticscholar +1 more source